Treatment of orthostatic hypotension

Current Opinion in Pharmacology

Volumn 2, Issue 6, 2002, Pages 740-747

  Oldenburg, Olaf ^a,b   Kribben, Andreas ^b   Baumgart, Dietrich ^b   Philipp, Thomas ^b   Erbel, Raimund ^b   Cohen, Michael V ^a  

^a UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMEZINIUM METILSULFATE; AMINE OXIDASE (FLAVIN CONTAINING); BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CATECHOLAMINE; CLONIDINE; DESMOPRESSIN; DIHYDROERGOTAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; FLUDROCORTISONE; INDOMETACIN; IRON DERIVATIVE; METOCLOPRAMIDE; MIDODRINE; MINERALOCORTICOID; MONOAMINE OXIDASE INHIBITOR; NORADRENALIN; OCTREOTIDE; PROSTAGLANDIN SYNTHASE INHIBITOR; RECOMBINANT ERYTHROPOIETIN; SEROTONIN UPTAKE INHIBITOR; SOMATOSTATIN DERIVATIVE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VASOCONSTRICTOR AGENT; VASOPRESSIN DERIVATIVE; YOHIMBINE; CARDIOVASCULAR AGENT;

ABDOMINAL PAIN; BALNEOTHERAPY; BEHAVIOR MODIFICATION; BLOOD PRESSURE MEASUREMENT; DIGESTIVE SYSTEM FUNCTION DISORDER; DRUG EFFICACY; DRUG MECHANISM; EDEMA; ENZYME INHIBITION; EXERCISE; FLUID INTAKE; GOOSEFLESH; HUMAN; HYPERTENSION; HYPOKALEMIA; HYPONATREMIA; NAUSEA; NEPHROTOXICITY; ORTHOSTATIC HYPOTENSION; PARESTHESIA; PRIORITY JOURNAL; PRURITUS; REVIEW; SALT INTAKE; SEDATION; STANDING; THOUGHT DISORDER; TILTING; URINE RETENTION; WATER INTOXICATION; WATER RETENTION; XEROSTOMIA; BODY POSTURE; PATHOPHYSIOLOGY; PHYSIOLOGY;

CARDIOVASCULAR AGENTS; HUMANS; HYPOTENSION, ORTHOSTATIC; POSTURE;

EID: 0036902303     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4892(02)00213-8     Document Type: Review

References (96)

1. Kapoor WN: Syncope. N Engl J Med 2000, 343:1856-1862.
2. Tilvis RS, Hakala SM, Valvanne J, Erkinjuntti T: Postural hypotension and dizziness in a general aged population: a four-year follow-up of the Helsinki Aging Study. J Am Geriatr Soc 1996, 44:809-814.
3. Masaki KH, Schatz IJ, Burchfiel CM, Sharp DS, Chiu D, Foley D, Curb JD: Orthostatic hypotension predicts mortality in elderly men. The Honolulu Heart Program. Circulation 1998, 98:2290-2295.
4. The Consensus Committee of the American Autonomic Society and the American Academy of Neurology: Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. Neurology 1996, 46:1470.
5. Ketch T, Biaggioni I, Robertson RM, Robertson D: Four faces of baroreflex failure: hypertensive crisis, volatile hypertension, orthostatic tachycardia, and malignant vagotonia. Circulation 2002, 105:2518-2523.
6. Low PA, Novak V, Spies JM, Novak P, Petty GW: Cerebrovascular regulation in the postural orthostatic tachycardia syndrome (POTS). Am J Med Sci 1999, 317:124-133.
7. Streeten DHP: Orthostatic intolerance. A historical introduction to the pathophysiological mechanisms. Am J Med Sci 1999, 317:78-87.
8. Jacob G, Biaggioni I: Idiopathic orthostatic intolerance and postural tachycardia syndromes. Am J Med Sci 1999, 317:88-101.
9. Robertson D: The epidemic of orthostatic tachycardia and orthostatic intolerance. Am J Med Sci 1999, 317:75-77.
10. Grubb BP, Karas B: Clinical disorders of the autonomic nervous system associated with orthostatic intolerance: an overview of classification, clinical evaluation, and management. Pacing Clin Electrophysiol 1999, 22:798-810.
11. Mitsky V, Robertson D: Failure of the autonomic nervous system. Compr Ther 1995, 21:529-534.
12. Oldenburg O, Mitchell A, Nürnberger J, Koeppen S, Erbel R, Philipp T, Kribben A: Ambulatory norepinephrine treatment of severe autonomic orthostatic hypotension. J Am Coll Cardiol 2001, 37:219-223.
13. Lamarre-Cliche M, Cusson J: The fainting patient: value of the head-up tilt-table test in adult patients with orthostatic intolerance. CMAJ 2001, 164:372-376.
14. Sutton R, Bloomfield DM: Indications, methology, and classification of results of tilt-table testing. Am J Cardiol 1999, 84:10Q-19Q.
15. Kapoor WN: Using a tilt table to evaluate syncope. Am J Med Sci 1999, 317:110-116.
16. Hakamäki T, Rajala T, Lehtonen A: Ambulatory 24-hour blood pressure recordings in patients with Parkinson's disease with and without fludrocortisone. Int J Clin Pharmacol Ther 1998, 36:367-369.
17. Oldenburg O, Sack S, Erbel R, Philipp T, Kribben A: Diagnosis of orthostatic hypotension. Dtsch Med Wschr 1999, 124:799-801.
18. Mathias CJ, Kimber JR: Postural hypotension: causes, clinical features, investigation, and management. Annu Rev Med 1999, 50:317-336.
19. Mathias CJ: Orthostatic hypotension: causes, mechanisms, and influencing factors. Neurology 1995, 45:S6-S11.
20. Robertson D, Mosqueda-Garcia R, Robertson RM, Biaggioni I: Chronic hypotension. In the shadow of hypertension. Am J Hypertens 1992, 5:200S-205S.
21. Robertson D, Davis TL: Recent advances in the treatment of orthostatic hypotension. Neurology 1995, 45:26-32.
22. Narkiewicz K, Cooly RL, Somers VK: Alcohol potentiates orthostatic hypotension. Implications for alcohol-related syncope. Circulation 2000, 101:398.
23. Mets TF: Drug-induced orthostatic hypotension in older patients. Drugs Aging 1995, 6:219-228.
24. Pang CCY: Autonomic control of the venous system in health and disease. Effects of drugs. Pharmacol Ther 2001, 90:179-230.
25. Mathias CJ, Fosbraey P, da Costa DF, Thornley A, Bannister R: The effect of desmopressin on nocturnal polyuria, overnight weight loss, and morning postural hypotension in patients with autonomic failure. BMJ 1986, 293:353-354.
26. Mathias CJ: A sound night's rest may do no good in autonomic failure! Clin Sci 2002, 101:619-620.
27. Jordan J, Shannon JR, Grogan E, Biaggioni I, Robertson D: A potent pressor response elicited by drinking water. Lancet 1999, 353:723.
28. Jordan J, Shannon JR, Black BK, Ali Y, Farley M, Costa F, Diedrich A, Robertson RM, Biaggioni I, Robertson D: The pressor response to water drinking in humans. A sympathetic reflex? Circulation 2000, 101:504-509.
29. Shannon JR, Diedrich A, Biaggioni I, Tank J, Robertson RM, Robertson D, Jordan J: Water drinking as a treatment for orthostatic syndromes. Am J Med 2002, 112:355-360.
30. Cariga P, Mathias CJ: Haemodynamics of the pressor effect of oral water in human sympathetic denervation due to autonomic failure. Clin Sci 2001, 101:313-319.
31. van Lieshout JJ, ten Harkel AD, Wieling W: Physical manoeuvres for combating orthostatic dizziness in autonomic failure. Lancet 1992, 339:897-898.
32. Bouvette CM, McPhee BR, Opfer-Gehrking TL, Low PA: Role of physical countermaneuvers in the management of orthostatic hypotension: efficacy and biofeedback augmentation. Mayo Clin Proc 1996, 71:847-853.
33. Tanaka H, Yamaguchi H, Tamai H: Treatment of orthostatic intolerance with inflateable abdominal band. Lancet 1997, 349:175.
34. Denq JC, Opfer-Gehrking TL, Giuliani M, Felten J, Convertino VA, Low PA: Efficacy of compression of different capacitance beds in the amelioration of orthostatic hypotension. Clin Auton Res 1997, 7:321-326.
35. Smit AA, Hardjowijono MA, Wieling W: Are portable folding chairs useful to combat orthostatic hypotension? Ann Neurol 1997, 42:975-978.
36. Ector H, Reybrouck T, Heidbüchel H, Gewillig M, van de Werf F: Tilt training: a new treatment for recurrent neurocardiogenic syncope and severe orthostatic hypotension. Pacing Clin Electrophysiol 1998, 21:193-196.
37. Reybrouck T, Heidbüchel H, van de Werf F, Ector H: Tilt training: a treatment for malignant and recurrent neurocardiogenic syncope. Pacing Clin Electrophysiol 2000, 23:493-498.
38. Di Girolamo E, Di Iorio C, Lenozio L, Sabatini P, Barsotti A: Usefulness of a tilt training program for the prevention of refractory neurocardiogenic syncope in adolescents. A controlled study. Circulation 1999, 100:1798-1801.
39. Cuddy RP, Smulyan H, Keighley JF, Markason CR, Eich RH: Hemodynamic and catecholamine changes during a standard cold pressor test. Am Heart J 1966, 71:446-454.
40. Kauppinen K: Sauna, shower, and ice water immersion. Physiological responses to brief exposures to heat, cool, and cold. Part II. Circulation. Arctic Med Res 1989, 48:64-74.
41. Oldenburg O, Sack S, Erbel R, Philipp T, Kribben A: Treatment of orthostatic hypotension. Dtsch Med Wschr 1999, 125:1209-1212.
42. Hermosillo AG, Márquez MF, Jáuregui-Renaud K, Cárdenas M: Orthostatic Hypotension, 2001. Cardiol Rev 2001, 9:339-347.
43. Senard JM, Montastruc JL: Which drug for which orthostatic hypotension? Fundam Clin Pharmacol 1996, 10:225-233.
44. Hussain RM, McIntosh SJ, Lawson J, Kenny RA: Fludrocortisone in the treatment of hypotensive disorders in the elderly. Heart 1996, 76:507-509.
45. Oldenburg O, Karliova M, Koeppen S, Weber F, Erbel R, Philipp T, Kribben A: Shy-Drager syndrome, a rare cause of orthostatic hypotension. Dtsch Med Wschr 1999, 124:8-12.
46. Gilden JL: Midodrine in neurogenic orthostatic hypotension. Int Angiol 1993, 12:125-131.
47. Low PA, Gilden JL, Freeman R, Sheng KN, McElligot MA: Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. J Am Med Assoc 1997, 277:1046-1051.
48. Wright RA, Kaufmann HC, Perera R, Opfer-Gehrking TL, McElligot MA, Sheng KN, Low PA: A double-blind, dose-response study of midodrine in neurogenic orthostatic hypotension. Neurology 1998, 51:120-124.
49. Fouad-Tarazi FM, Okabe M, Goren H: Alpha sympathomimetic treatment of autonomic insufficiency with orthostatic hypotension. Am J Med 1995, 99:604-610.
50. Samniah N, Sakaguchi S, Lurie KG, Iskos D, Benditt DG: Efficacy and safety of midodrine hydrochloride in patients with refractory vasovagal syncope. Am J Cardiol 2001, 88:80-83.
51. Mitro P, Trejbal D, Rybar AR: Midodrine hydrochloride in the treatment of vasovagal syncope. Pacing Clin Electrophysiol 1999, 22:1620-1624.
52. Perez-Lugones A, Schweikert R, Pavia S, Sra J, Akhtar M, Jaeger F, Tomassoni GF, Saliba W, Leonelli FM, Bash D et al.: Usefulness of midorine in patients with severely symptomatic neurocardiogenic syncope: a randomized control study. J Cardiovasc Electrophysiol 2001, 12:935-938.
53. Bannister R, Davies B, Holly E, Rosenthal T, Sever P: Defective cardiovascular reflexes and supersensitivity to sympathomimetic drugs in autonomic failure. Brain 1979, 102:163-176.
54. Shannon J, Jordan J, Costa F, Robertson RM, Biaggioni I: The hypertension of autonomic failure and its treatment. Hypertension 1997, 30:1062-1067.
55. Onrot J, Goldberg MR, Biaggioni I, Wiley RG, Hollister AS, Robertson D: Oral yohimbine in human autonomic failure. Neurology 1987, 37:215-220.
56. Brodde EO, Anlauf M, Arroyo J, Wagner R, Weber F, Buck KD: Hypersensitivity of adrenergic receptors and blood-pressure response to oral yohimbine in orthostatic hypotension. N Engl J Med 1983, 308:1033-1034.
57. Jordan J, Shannon JR, Biaggioni I, Norman R, Black BK, Robertson D: Contrasting actions of pressor agents in severe autonomic failure. Am J Med 1998, 105:116-124.
58. Verwaerde P, Tran MA, Montastruc JL, Senard JM, Portolan G: Effects of yohimbine, an alpha-2-adrenoceptor antagonist, on experimental neurogenic orthostatic hypotension. Fundam Clin Pharmacol 1997, 11:567-575.
59. Harada K, Ohmori M, Fujimura A, Ohashi K: Effect of amezinium metilsulfate on the finger skin vasoconstrictor response to cold stimulation and venoconstrictor response to noradrenaline. Jpn Circ J 1998, 62:824-828.
60. Dominiak P, Kees F, Welzel D, Grobecker H: Cardiovascular parameters and catecholamines in volunteers during passive orthostatis. Influence of antihypotensive drugs. Arzneimittelforschung 1992, 42:637-642.
61. Kita K, Hirayama K: Treatment of neurogenic orthostatic hypotension with amezinium metilsulfate, a new indirect sympathomimetic drug. Neurology 1988, 38:1095-1099.
62. Thulesius O: Pathophysiological classification and diagnosis of orthostatic hypotension. Cardiology 1976, 61 (Suppl 1):180-190.
63. Biaggioni I, Robertson D, Krantz S, Jones M, Haile V: The anemia of primary autonomic failure and its reversal with recombinant erythropoietin. Ann Intern Med 1994, 121:181-186.
64. Robertson D, Krantz S, Biaggioni I: The anemia of microgravity and recumbency: role of sympathetic neural control of erythropoietin production. Acta Astronaut 1994, 33:137-141.
65. Hoeldtke RD, Streeten DHP: Treatment of orthostatic hypotension with erythropoietin. N Engl J Med 1993, 329:611-615.
66. Asahara K, Ando Y, Tanaka Y, Yi S, Yamashita T, Ando M: Secondary hypoplastic anemia in patients with familiar amyloidotic polyneuropathy. Acta Haematol 1993, 90:130-135.
67. Ando Y, Asahara K, Obayashi K, Suhr O, Yonemitsu M, Yamashita T, Tashima K, Uchino M, Ando M: Autonomic dysfunction and anemia in neurologic disorders. J Auton Nerv Syst 1996, 61:145-148.
68. Winkler AS, Landau S, Watkins PJ: Erythropoietin treatment of postural hypotension in anemic type 1 diabetic patients with autonomic neuropathy. Diabetes Care 2001, 24:1121-1123.
69. Hoeldtke RD, O'Dorisio TM, Boden G: Treatment of autonomic neuropathy with a somatostatin analogue SMS-201-995. Lancet 1986, II:602-605.
70. Hoeldtke RD, Davis KM, Joseph J, Gonzales R, Panidis IP, Friedman AC: Hemodynamic effects of octreotide in patients with autonomic neuropathy. Circulation 1991, 84:168-176.
71. Hoeldtke RD, Horvath GG, Bryner KD, Hobbs GR: Treatment of orthostatic hypotension with midodrine and octreotide. J Clin Endocrinol Metab 1998, 83:339-343.
72. Hoeldtke RD, Israel BC: Treatment of orthostatic hypotension with octreotide. J Clin Endocrinol Metab 1989, 68:1051-1059.
73. Robertson D, Goldberg MR, Hollister AS, Wade D, Robertson RM: Clonidine raises blood pressure in severe idiopathic orthostatic hypotension. Am J Med 1983, 74:193-200.
74. Senard JM, Arias A, Berlan M, Tran MA, Rascol A, Montastruc JL: Pharmacological evidence of alpha 1- and alpha 2-adrenergic supersensitivity in orthostatic hypotension due to spinal cord injury: a case report. Eur J Clin Pharmacol 1991, 41:593-596.
75. Kuchel O, Buu NT, Gutkowska J, Genest J: Treatment of severe orthostatic hypotension by metoclopramide. Ann Intern Med 1980, 93:841-843.
76. Takeda R, Takeda Y, Koshida H, Ikeda M, Yasuhara S, Nagai K, Morise T, Miyamori I: Effect of metoclopramide on orthostatic hypotension in diabetes mellitus: failure to demonstrate the role of vasoconstrictive hormones. Exp Clin Endocrinol 1988, 91:197-201.
77. Bessa AM, Zanella MT, Saragoca MA, Mulinari RA, Czepielewski M, Ribeiro AB, Ramos OL: Acute hemodynamic and humoral effects of metoclopramide on blood pressure control improvement in subjects with diabetic orthostatic hypotension. Clin Pharmacol Ther 1984, 36:738-744.
78. Magnifico F, Pierangeli G, Barletta G, Candela C, Bonavina G, Contin M, Cortelli P: The cardiovascular effects of metoclopramide in multiple system atrophy and pure autonomic failure. Clin Auton Res 2001, 11:163-168.
79. Imaizumi T, Takeshita A, Ashihara T, Nakamura M, Tsuji S, Shibazaki H: Increase in refelx vasoconstriction with indomethacin in patients with orthostatic hypotension and central nervous system involement. Br Heart J 1984, 52:581-584.
80. Abate G, Polimeni RM, Cuccurullo F, Puddu P, Lenzi S: Effects of indomethacin on postural hypotension in Parkinsonism. BMJ 1979, 8:1466-1468.
81. Hannemann J, Rob PM, Vieregge P, Kerner W, Sack K: Shy-Drager syndrome - therapy experience with indomethacin. Med Klin 1995, 90:435-438.
82. Tsuda Y, Kimura K, Yoneda S, Asai T, Handa N, Tanouchi J, Inoue M, Abe H: Hemodynamics in Shy-Drager syndrome and treatment with indomethacin. Eur Neurol 1983, 22:421-427.
83. Montastruc JL, Pelat M, Verwaerde P, Brefel-Courbon C, Tran MA, Blin O, Rascol O, Senard JM: Fluoxetine in orthostatic hypotension of Parkinson's disease: a clinical and experimental pilot study. Fundam Clin Pharmacol 1998, 12:398-402.
84. Di Girolamo E, Di Iorio C, Sabatini P, Lenozio L, Barbone C, Barsotti A: Effects of paroxetine hydrochloride, a selective serotonine reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 1999, 33:1227-1230.
85. Grubb BP, Samoil D, Kosinski D, Kip K, Brewster P: Use of sertraline hydrochloride in the treatment of refractory neurocardiogenic syncope in children and adolescents. J Am Coll Cardiol 1994, 24:490-494.
86. Liu B, Anderson G, Mittmann N, To T, Axcell T, Shear N: Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people. Lancet 1998, 351:1303-1307.
87. Dendi R, Goldstein DS: Meta-analysis of nonselective versus β-1 adrenoceptor-selective blockade in prevention of tilt-induced neurocardiogenic syncope. Am J Cardiol 2002, 89:1319-1321.
88. Ammirati F, Colivicchi F, Santini M: Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope. A multicenter, randomized, controlled trial. Circulation 2001, 104:52-57.
89. Oldenburg O, Erbel R, Fritschka E, Philipp T, Kribben A: Ambulatory norepinephrine infusion in severe idiopathic orthostatic hypotension (Bradbury-Eggleston syndrome). Cardiovasc Drugs Ther 1999, 13:355-356.
90. Kribben A, Bremer C, Fritschka E, Koeppen S, Ahrens O, Philipp T: Ambulatory infusion of noradrenaline for long-term treatment of Shy-Drager syndrome. Kidney Blood Pres Res 1998, 21:70-73.
91. Schatz IJ: Treatment of severe autonomic orthostatic hypotension. Lancet 2001, 357:1060-1061.
92. Kuchel O, Buu NT, Hamet P, Larochelle P, Gutkowska J, Schiffrin EL, Bourque M, Genest J: Orthostatic hypotension: a posture-induced hyperdopaminergic state. Am J Med Sci 1985, 289:3-11.
93. Kapoor WN. Current evaluation and management of syncope. Circulation 2002, 106:1606-1609.
94. Krediet CT, van Dijk N, Linzer M, van Lieshout JJ, Wieling W: Management of vasovagal syncope. Controlling or aborting faints by leg crossing and muscle tensing. Circulation 2002, 106: 1684-1689.
95. Takata TS, Wasmund SL, Smith ML, Li JM, Joglar JA, Banks K, Kowal RC, Page RL, Hamdan MH: Serotonin reuptake inhibitor (Paxil) does not prevent the vasovagal reaction associated with carotid sinus massage and/or lower body negative pressure in healthy volunteers. Circulation 2002, 106:1500-1504.
96. Mosqueda-Garcia R, Furlan R, Tank J, Fernandez-Violante R: The elusive pathophysiology of neurally mediated syncope. Circulation 2000, 102:2898-2906.